New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding

Nephrology Dialysis Transplantation

Volumn 18, Issue 2, 2003, Pages 252-257

  Chanard, Jacques ^a   Lavaud, Sylvie ^a   Randoux, Christine ^a   Rieu, Philippe ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Biocompatibility; Dialysis membranes; Extracorporeal devices; Haemodialysis

Indexed keywords

ALPHA TOCOPHEROL; ANTITHROMBIN III; BRADYKININ; CELLULOSE; HEPARIN; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; POLITEF; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYAMIDE; POLYSULFONE; THROMBOCYTE FACTOR 4; URATE OXIDASE;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BIOCOMPATIBILITY; BLOOD CLOTTING; BLOOD COMPATIBILITY; DIALYSIS MEMBRANE; DRUG ADSORPTION; EDITORIAL; ENZYME BLOOD LEVEL; EXTRACORPOREAL CIRCULATION; HUMAN; NUTRITION; OSTEOPOROSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENESIS; ZETA POTENTIAL;

ADSORPTION; ANTICOAGULANTS; ARTERIOSCLEROSIS; BIOCOMPATIBLE MATERIALS; COATED MATERIALS, BIOCOMPATIBLE; HEPARIN; HUMANS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 0037317065     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.2.252     Document Type: Editorial

References (63)

1. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F. Carpal tunnel syndrome and type of dialysis membrane. Br Med J 1989; 298: 867-869
2. Van Ypersèle de Strihou C, Jadoul M, Malgehem B, Jamart J, the Working Party on Dialysis Amyloidosis. Effects of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012-1019
3. 2 microglobulin turnover in dialyzed patients. Kidney Int 1992; 42: 1434-1443
4. Chanard J, Vincent C, Caudwell V, Lavaus S, Toupance O, Wong T, Revillard JP. Beta2-microglobulin metabolism in uremic patients who are undergoing dialysis. Kidney Int 1993; 43 (Suppl 41): 583-587
5. Jaber BL, Pereira BJG. Dialysis reactions. Semin Dial 1997; 10: 158-165
6. Tielemans C, Madhoun P, Lenaers M, Schandene L, Goldman M, Vanderweghem JL. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 1990; 38: 982-984
7. Verresen L, Waer M, Vanrenterghem Y, Michielsen P. Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 1990; 336: 1360-1362
8. Matsuda T. Biological responses at non-physiological interfaces and molecular design of biocompatible surfaces. Nephrol Dial Transplant 1989; 4 (Suppl 3): 560-566
9. Babb AL, Strand MJ, Uvelli DA, Milutinovic J, Scribner BH. Quantitative description of dialysis treatment: a dialysis index. Kidney Int 1975; 2: S23-S29
10. Brunois JP, Melin JP, Lavaud S, Chanard J. Effect of the hemodialysis prescription on morbidity. N Engl J Med 1982; 306: 1237-1238
11. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 2002; 13: S45-S47
12. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: the interkeukin-1 hypothesis. Blood Purif 1983; 1: 3-8
13. Lonneman G, Haubitz M, Schindler R. Hemodialysis-associated induction of cytokines. Blood Purif 1990; 8: 214-222
14. Pereira B. Cytokine production in patients on dialysis. Blood Purif 1995; 13: 135-146
15. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine M, Haeffner-Cavaillon N. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxines. Kidney Int 1990; 38: 1089-1094
16. Cheung AK, Parker C, Wilcox L, Janatova J. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990; 37: 1055-1059
17. Clark WR, Hamburger RJ, Lysaght J. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int 1999; 56: 2005-2015
18. European Best Practice Guidelines for Haemodialysis. Nephrol Dial Transplant 2002; 17 (Suppl 7)
19. Renaux JL, Thomas M, Crost T, Loughraieb N, Vantard G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution and pH. Kidney Int 1999; 55: 1097-1103
20. Hakim RM, Breillatt J, Lazarus M, Port FK, Eknoyan G. Complement activation and hypersensitivity reaction to dialysis membranes. N Engl J Med 1984; 311: 877-917
21. Hakim R, Fearon D, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26: 194-200
22. Dinarello CA. Cytokines: agents provocateurs in hemodialysis? Kidney Int 1992; 41: 683-694
23. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamp-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990; 37: 116-125
24. Seyfert UT, Helmling E, Hauck W et al. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes. Nephrol Dial Transplant 1991; 6: 428-434
25. Mulvihill J, Crost T, Renaux JL, Cazenave JP. Evaluation of hemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers. Nephrol Dial Transplant 1997; 12: 1968-1973
26. Tetta C, David S, Mariano F, Denitti C, Panichi V. Alterations of the cytokine network in hemodialysis. J Nephrol 2001; 14 (Suppl 4): S22-S29
27. Pascal M, Schifferli J. Adsorption of complement factor D by polyacrylonitrile dialysis membrane. Kidney Int 1996; 43: 903-911
28. Sultan Y, London GM, Goldfarb B et al. Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membrane. Nephrol Dial Transplant 1990; 5: 362-368
29. Lindhout T. Biocompatibility of extracorporeal blood treatment-selection of haemostatic parameters. Nephrol Dial Transplant 1994; 9: 83-85
30. Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interaction during hemodialysis. Kidney Int 1999; 56: 1578-1583
31. Franck RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J. Role of contact system activation in hemodialyzer induced thrombogenicity. Kidney Int 2001; 60: 1972-1981
32. Lonneman G, Schindler R, Luftt V, Mahiout A, Shaldon S, Koch KM. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. Nephrol Dial Transplant 1995; 10: 207-211
33. Henderson L. Biophysics of ultrafiltration and hemofiltration. In: Jacobs C, Kjellstrand C, Kock K, Winchester J (eds) Replacement of Renal Function by Dialysis, 4th Ed. Klower Academic Publishers, Dordrecht, The Netherlands: 1996: 114-145
34. Adam A, Blais C, Loute G. Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors. Nephrologie 2000; 21: 163-172
35. Sagedal S, Hartmann A, Sundstrom K, Bjornsen S, Brosstad F. Anticoagulation intensity sufficient for hemodialysis does not prevent activation of coagulation and platelets. Nephrol Dial Transplant 2001; 16: 987-993
36. 2 microglobulin in hemodialysis patients: assessment using total body counting. Artif Organs 1998; 22: 574-580
37. Moachon N, Boullanger C, Fraud S, Vial E, Thomas M, Quash G. Influence of the charge of low molecular weight proteins on their efficacy of filtration and/or adsorption on dialysis membranes with different intrinsic properties. Biomaterials 2002; 23: 651-658
38. Valette P, Thomas M, Dejardin P. Adsorption of low molecular weight proteins to hemodialysis membranes: experimental results and stimulations. Biomaterials 1999; 20: 1621-1634
39. Thomas M, Valette P, Mausset AL, Dejardin P. High molecular weight kininogen adsorption on hemodialysis membranes: influence of pH and relationship with contact phase activation of blood plasma-influence of pre-treatment with poly(ethyleneimine). Int J Artif Organs 2000; 23: 20-26
40. 2-microglobulin by charged and neutral dialysis membranes. Kidney Int 2001; 60: 1571-1577
41. Chanard J, Toupance O, Gillery P, Lavaud S. Evaluation of protein loss during hemofiltration. Kidney Int 1988; 33 (Suppl 24): S114-S116
42. Deppisch R, Gohl H, Smeby L. Microdomain structure of polymeric surfaces: potential for improving blood treatment procedure. Nephrol Dial Transplant 1998; 13: 1354-1359
43. Ouseph R, Ward RA. Anticoagulation for intermittent hemodialysis. Semin Dial 2000; 13: 181-187
44. Ourum E, Mollnes TE, Fosse E et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 1995; 110: 1623-1632
45. Fukutomi M, Kobayashi S, Niwaya K, Hamada Y, Kitamura S. Changes in platelet, granulocyte and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs 1996; 20: 767-776
46. Garred P, Mollnes TE. Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules. Artif Organs 1997; 21: 293-299
47. Wright MJ, Woodrow G, Umpleby S, Hull S, Brownjohn AM, Turney JH. Low thrombogenecity of polyethylene glycol grafted cellulose membranes does not influence heparin requirements in hemodialysis. Am J Kidney Dis 1999; 34: 36-42
48. Hamada Y, Kawachi K, Nakata T, Kohtani T, Takano S, Tsunooka N. Antiinflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery. Artif Organs 2001; 25: 1004-1008
49. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999; 16: 342-350
50. Lavaud S, Canivet E, Mohajer M et al. Changes in membrane electronegativity induces heparin sparing for hemodialysis. J Am Soc Nephrol 2000; 11: 281A (abstract)
51. Delawari E, Renaux JL, Galland R, Pachot M, Traeger J. Benefits of AN69-ST membrane on heparin-free dialysis. Nephrol Dial Transplant 2001; 16: A174 (abstract)
52. Chan MK, Persand J, Varghese Z, Moorhead J. Pathogenic roles of post-heparin lipases in lipid adnormalities in hemodialysis. Kidney Int 1984; 25: 812-820
53. Massy Z, Kasiske BL. Hyperlipidemia and its management in renal disease. Curr Opin Nephrol Hypertens 1996; 5: 141-146
54. Keuren JF, Wielders SJ, Willems GM, Mona M, Lindhout T. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood. Thromb Haemost 2002; 87: 742-747
55. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J. Effect of in vivo contact between blood and dialysis membrane on protein catabolism in humans. Kidney Int 1990; 38: 487-494
56. Ikizler TA, Pupim LB, Brouillette JR et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 2002; 282: E107-E116
57. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557
58. Maseri A. Inflammation, atherosclerosis and ischemic events: exploring the hidden site of the moon. N Engl J Med 1997; 336: 1014-1016
59. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143
60. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29: 658-668
61. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Eng J Med 1997; 336: 973-979
62. Koenig W, Sund M, Fröhlich M et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999; 99: 237-242
63. Leitienne P, Fouque D, Rigal D, Adeleine P, Trzeciak MC, Laville M. Heparin and blood polymorphonuclear stimulation in hemodialysis: an expansion of the biocompatibility concept. Nephrol Dial Transplant 2000; 15: 1631-1637